Donald P Kotler Selected Research

HIV-Associated Lipodystrophy Syndrome

1/2011	Lipodystrophy in HIV patients: its challenges and management approaches.
1/2009	The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications.
2/2004	Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy.
5/2003	Preferential loss of omental-mesenteric fat during growth hormone therapy of HIV-associated lipodystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donald P Kotler Research Topics

Disease

11	HIV Infections (HIV Infection) 07/2014 - 08/2002
8	Insulin Resistance 03/2016 - 10/2006
7	Infections 06/2016 - 11/2002
4	Dyslipidemias (Dyslipidemia) 01/2011 - 03/2004
4	HIV-Associated Lipodystrophy Syndrome 01/2011 - 05/2003
4	Lipodystrophy 01/2008 - 01/2003
3	Abdominal Obesity 03/2016 - 05/2011
3	Fibrosis (Cirrhosis) 05/2015 - 02/2002
2	HIV Enteropathy 01/2014 - 01/2003
2	Obesity 07/2007 - 10/2006
2	Weight Loss (Weight Reduction) 03/2006 - 04/2004
2	Body Weight (Weight, Body) 03/2006 - 04/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2002 - 11/2002
1	Deglutition Disorders (Dysphagia) 12/2020
1	Anemia 01/2019
1	Colitis 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Inflammation (Inflammations) 03/2016
1	Liver Diseases (Liver Disease) 09/2015
1	Drug-Related Side Effects and Adverse Reactions 05/2015
1	Hepatocellular Carcinoma (Hepatoma) 05/2015
1	Premature Aging 07/2014
1	Hypertrophy 01/2014
1	Type 2 Diabetes Mellitus (MODY) 05/2011
1	Diabetes Mellitus 02/2011
1	Diarrhea 05/2010
1	Enterocolitis 05/2010
1	Hepatitis C 03/2009
1	Coinfection 03/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2008
1	Atherosclerosis 03/2008
1	Septic Shock (Toxic Shock Syndrome) 06/2007
1	Fever (Fevers) 06/2007
1	Weight Gain 01/2007
1	Glucose Intolerance 01/2007
1	Proctitis 05/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2003
1	Osteoporosis 04/2002
1	Fatty Liver 02/2002

Drug/Important Bio-Agent (IBA)

8	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 11/2002
5	Human Growth Hormone (Saizen)FDA LinkGeneric 03/2016 - 08/2002
4	Growth Hormone (Somatotropin)IBA 11/2006 - 05/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2016 - 05/2006
3	LipidsIBA 03/2009 - 10/2006
2	Rosiglitazone (Avandia)FDA Link 03/2016 - 01/2013
2	AdiponectinIBA 03/2016 - 01/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2009 - 03/2008
2	Insulin (Novolin)FDA Link 01/2008 - 10/2006
2	CytokinesIBA 02/2004 - 04/2003
2	MineralsIBA 11/2002 - 04/2002
1	Phenobarbital (Luminal)FDA Link 12/2020
1	ElectrolytesIBA 01/2019
1	FidaxomicinIBA 01/2019
1	Guanosine Diphosphate (GDP)IBA 09/2015
1	telaprevirIBA 05/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 05/2015
1	Ribavirin (Virazole)FDA LinkGeneric 05/2015
1	Interferon-alpha (Interferon Alfa)IBA 05/2015
1	AntigensIBA 07/2014
1	Vitamin D FDA LinkGeneric 02/2011
1	Triglycerides (Triacylglycerol)IBA 02/2011
1	RNA (Ribonucleic Acid)IBA 06/2008
1	Fibrinogen (Factor I)FDA Link 03/2008
1	AdipokinesIBA 01/2008
1	LeptinIBA 01/2008
1	Octreotide (Sandostatin)FDA LinkGeneric 06/2007
1	Transaminases (Aminotransferases)IBA 02/2007
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2007
1	Antiviral Agents (Antivirals)IBA 10/2006
1	Plasminogen Activator Inhibitor 1IBA 10/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2006
1	Oxandrolone (Anavar)FDA LinkGeneric 03/2006
1	Proteins (Proteins, Gene)FDA Link 08/2004
1	Glycerol (Glycerine)FDA LinkGeneric 02/2004
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2004
1	SodiumIBA 01/2003
1	Neutralizing AntibodiesIBA 01/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003
1	des-Arg-(77)- complement C3aIBA 01/2003
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2003
1	Complement System Proteins (Complement)IBA 01/2003

Therapy/Procedure

11	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 05/2003
9	Therapeutics 03/2016 - 11/2002
1	Fecal Microbiota Transplantation 01/2019
1	Fluid Therapy (Oral Rehydration Therapy) 06/2016
1	Duration of Therapy 05/2015
1	Liver Transplantation 05/2015
1	Bariatric Surgery 02/2002